Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1988)	10/18/2007 1:28:14 PM
From: Jibacoa	Respond to of 3722

AXK is having a nice spike today & is up > 60% <g> bigcharts.marketwatch.com biz.yahoo.com Accelr8 Announces Patent Allowance for Rapid Bacterial Diagnostic Method Thursday October 18, 8:00 am ET New Patent Supports BACcel(R) Rapid Analysis of ''Superbugs'' - Multiple Drug Resistant Bacteria DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (AMEX:AXK - News) announced today that it received notice of allowance on the first patent related to its BACcel® rapid diagnostic platform. The methods enable the BACcel system to quickly identify major multiple drug resistant (MDR) bacteria and their resistance mechanisms. Familiar examples of MDR bacteria, often called “superbugs” by the press, include MRSA (methicillin resistant Staphylococcus aureus), Acinetobacter, and Pseudomonas. The BACcel system rapidly identifies bacteria and their major resistance mechanisms,and eliminates the need for cultures. Today’s standard lab methods typically require 2-3 days to perform tests because they require extensive growth of bacterial cultures. The BACcel can identify and count bacteria within 2 hours after specimen access, and identify major resistance mechanisms within 6 hours. The new patent covers methods used in the BACcel, and also claims alternative methods that a competitor might otherwise use to circumvent the BACcel’s specific design. Snip AXK had already reported progress on the BACcel system on Sep 27, when it claimed that its scientists could measure bacterial growth in less than 10 minutes after a sample extraction. biz.yahoo.com But at that time, there wasn't as much interest in the subject as now a days with the MRSA been brought into the lime light after problems at a school in Virginia. bigcharts.marketwatch.com AXK doesn't have significant LTD. The insiders reportedly hold around 15% & the float is around 8.2M. It seems that the R/R isn't bad at present levels & the stock has a chance of getting back to the $5 level.<g> bigcharts.marketwatch.com Bernard